Leave a message
info@auctorespublishing.com
+1-(302)-520-2644
+1-(302)-520-2644

Endoscopic Laser and Laparoscopic Surgery of Oesophageal Cancer Compared with Surgery Alone for Localized Esophageal Cancer

  1. Home
  2. Journals
  3. Archives of Medical Case Reports and Case Study
  4. Archives
Submit Guidelines

Review Article | DOI: https://doi.org/10.31579/2692-9392/199

Endoscopic Laser and Laparoscopic Surgery of Oesophageal Cancer Compared with Surgery Alone for Localized Esophageal Cancer

  • Alireza Heidari 1,2*

1 Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA and BioSpectroscopy Core Research Laboratory (BCRL), California South University, 14731 Comet St. Irvine, CA 92604, USA.
2Cancer Research Institute (CRI), California South University, 14731 Comet St. Irvine, CA 92604, USA and American International Standards Institute (AISI), Irvine, CA 3800, USA.

*Corresponding Author: Alireza Heidari, serves as A.T. Still University's assistant vice President for clinical education development.

Citation: Alireza Heidari, (2024), Endoscopic Laser and Laparoscopic Surgery of Oesophageal Cancer Compared with Surgery Alone for Localized Esophageal Cancer, Archives of Medical Case Reports and Case Study, 9(1); DOI:10.31579/2692-9392/199

Copyright: © 2024, Alireza Heidari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 19 December 2023 | Accepted: 26 December 2023 | Published: 15 January 2024

Keywords: .

Abstract

.

Even though there may be the existence of the non-stop development of ordinary and (development or increase over the years/collection of events or matters)-unfastened survival [1,2], extra than 50 % of girls with a preliminary (identification of a disease or hassle, or its reason) of superior ovarian most cancers experience repeating disorder [2]. because of this, defining the high-quality medically useful technique for repeating ovarian cancer (ROC) patients is really a (very critical thing/huge stone laid at the nook of a building) for gynecologic cancer medical doctors. so as to establish an powerful treatment set of pc commands, the category of repeating disease has been based in at the least the remaining 20 years at the time went via from the completion of first (or most crucial) platinum-containing (using powerful drugs to assist cure disorder) and the occasion of go back of disease (i.e., platinum-free period of time (or space)) [3,4]. mainly, ladies showing ROC greater than 6 months after first-line (using powerful drugs to help treatment disorder) are carefully concept about/believed to have platinum-sensitive sickness, this way going through platinum challenge and (system of identifying the well worth, quantity, or satisfactory of something) for surgical removal of repeating disease [5-11]. on the other hand, repeating ovarian cancer (ROC) patients displaying return of disorder within the first 6 months after finishing touch of platinum-primarily based (the usage of powerful capsules to assist therapy disease) are described as platinum resistant, being correct most effective for ache-relieving care given the fast survival [7].

However, this very strict disease category has been challenged over the previous few years with the approaching of (high) first-class remedy and the introduction of custom-designed (achievement plans/approaches of reaching dreams) for cancer treatment [12]. especially, (records or bodily gadgets that actually prove something) strongly hints that further to platinum-unfastened time frame (or space) (PFI), performance reputation [6,11], histological features, diffusion, and localization [13,14] of go back of disorder ought to be carefully thought approximately/believed within the decision-primarily based set of computer commands (associated with/searching at/thinking about) the management of women with ROC (Fig. 1). For these motives, even though cytoreductive surgery stays an ability medically useful choice most effective in ladies with platinum-touchy ailment, developing interest has been (now not very lengthy in the past) focused at the function of surgical treatment in patients with platinum-resistant ailment.

Especially, preliminary promising reviews have been published (associated with/looking at/thinking about) the role of secondary cytoreductive surgical procedure (SCS) in girls with (only occurring or existing in one small location) platinum-resistant go back of sickness [15-17], and study how matters have been inside the beyond analyses have (no longer very lengthy ago) supported the function of surgical treatment mixed with intraperitoneal (associated with dangerously excessive frame temperature) (using effective pills to assist therapy sickness) (HIPEC) in treating peritoneal return of disease within 6 months from of entirety of first (or most vital) platinum-based (the use of effective tablets to assist cure disease) [18], [19-21]. what's extra, novel (event(s) or object(s) that show something) seems to suggest that room may also exist for SCS in girls with platinum-resistant ROC displaying low-grade histology [22]. ultimately, the feasible gain of barely harmful surgical approaches to enhance high-quality of existence (QoL) and signal of illness alleviation in the massive photograph of ache-relieving care ought to not be underestimated [23-25].

Therefore, the intention of our evaluate e-book is to summarize the to be had (event(s) or object(s) that prove something) (associated with/looking at/thinking about) the function of surgery in women with platinum-resistant ROC, looking to recognize which patients may additionally gain from this hard, experimental technique [1-114]. 

Acknowledgement

This study was supported by the Cancer Research Institute (CRI) Project of Scientific Instrument and Equipment Development, the National Natural Science Foundation of the United Sates, the International Joint Bio Spectro scopy Core Research Laboratory (BCRL) Program supported by the California South University (CSU), and the Key project supported by the American International Standards Institute (AISI), Irvine, California, USA.

References

  1. A. Heidari, (2017), “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Med Oncol. Vol. 1 No. 1: 1,
    View at Publisher | View at Google Scholar
  2. A. Heidari, (2017), “A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation”, Am J Ethnomed, Vol. 4 No. 1: 10,
    View at Publisher | View at Google Scholar
  3. A. Heidari, (2017),“Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiation”, J Med Chem Toxicol, 2 (3): 1–5.
    View at Publisher | View at Google Scholar
  4. A. Heidari, (2017),“Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment”, Parana Journal of Science and Education (PJSE)–v.3, n.4, (10–19) October 12.
    View at Publisher | View at Google Scholar
  5. A. Heidari, (2017), “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”, Open J Anal Bioanal Chem 1 (1): 014–020.
    View at Publisher | View at Google Scholar
  6. A. Heidari, (2017), “Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity”, Enz Eng 6: 1.
    View at Publisher | View at Google Scholar
  7. A. Heidari, (2017), “Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)”, Mod Appro Drug Des. 1 (1). MADD.000504.
    View at Publisher | View at Google Scholar
  8. A. Heidari, (2017), “Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS) and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells”, J Proteomics Enzymol 6: 1.
    View at Publisher | View at Google Scholar
  9. A. Heidari, (2017) ,“Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation”, J Pharm Pharmaceutics 4 (2): 1–5.
    View at Publisher | View at Google Scholar
  10. A. Heidari, C. Brown, (2017) “Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems”, Ann Adv Chem. 1 (2): 061–069.
    View at Publisher | View at Google Scholar
  11. A. Heidari, (2017), “High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation”, J Transl Res. 1 (1): 1–3.
    View at Publisher | View at Google Scholar
  12. A. Heidari, (2017), “Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica”, Current Trends Anal Bioanal Chem, 1 (1): 36–41.
    View at Publisher | View at Google Scholar
  13. A. Heidari, (2017), “Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiation”, Arch Biotechnol Biomed. 1 (1): 067–0100.
    View at Publisher | View at Google Scholar
  14. A. Heidari, (2017), “Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiation”, SOJ Mater Sci Eng 5 (2): 1–6.
    View at Publisher | View at Google Scholar
  15. A. Heidari, (2017), “Cavity Ring–Down Spectroscopy (CRDS), Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Challenges Cancer Detect Ther 4 (2): e001.
    View at Publisher | View at Google Scholar
  16. A. Heidari, (2017), “Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Hepatol Gastroenterol, 3 (4): 079–084.
    View at Publisher | View at Google Scholar
  17. A. Heidari, (2017), “Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Pharmacovigilance and Drug Safety 4 (2): e001.
    View at Publisher | View at Google Scholar
  18. A. Heidari, (2017), “Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts) on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiation”, Open J Anal Bioanal Chem 1 (1): 021–026.
    View at Publisher | View at Google Scholar
  19. A. Heidari, (2017), “Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR) Spectroscopy and Electron Spin Resonance (ESR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Austin J Anal Pharm Chem. 4 (3): 1091.
    View at Publisher | View at Google Scholar
  20. A. Heidari, (2017), “Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLAB”, Madridge J Nano Tech. Sci. 2 (2): 77–83.
    View at Publisher | View at Google Scholar
  21. A. Heidari, (2017), “A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO) Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO) Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancers”, Cancer Clin Res Rep, 1: 2, e001.
    View at Publisher | View at Google Scholar
  22. A. Heidari, (2017), “A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiation”, Cancer Sci Res Open Access 4 (2): 1–8.
    View at Publisher | View at Google Scholar
  23. A. Heidari, (2017), “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Oral Cancer Res 1 (1): 12–17.
    View at Publisher | View at Google Scholar
  24. A. Heidari, (2017), “Vibrational Decihertz (dHz), Centihertz (cHz), Millihertz (mHz), Microhertz (μHz), Nanohertz (nHz), Picohertz (pHz), Femtohertz (fHz), Attohertz (aHz), Zeptohertz (zHz) and Yoctohertz (yHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, International Journal of Biomedicine, 7 (4), 335–340.
    View at Publisher | View at Google Scholar
  25. A. Heidari, (2017),“Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, EC Cancer, 2 (5), 239–246.
    View at Publisher | View at Google Scholar
  26. A. Heidari, (2017), “Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, BAOJ Cancer Res Ther, 3: 3, 045–052.
    View at Publisher | View at Google Scholar
  27. A. Heidari, (2017), “J–Spectroscopy, Exchange Spectroscopy (EXSY), Nucle¬ar Overhauser Effect Spectroscopy (NOESY) and Total Correlation Spectroscopy (TOCSY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Eng Sci J, 1 (2): 006–013.
    View at Publisher | View at Google Scholar
  28. A. Heidari, (2017), “Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Biopharm Sci, 1: 103–107.
    View at Publisher | View at Google Scholar
  29. A. Heidari, (2017), “Vibrational Decahertz (daHz), Hectohertz (hHz), Kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Madridge J Anal Sci Instrum, 2 (1): 41–46.
    View at Publisher | View at Google Scholar
  30. A. Heidari, (2018), “Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Mater Sci Nanotechnol 6 (1): 101.
    View at Publisher | View at Google Scholar
  31. A. Heidari, (2018), “Fourier Transform Infrared (FTIR) Spectroscopy, Near–Infrared Spectroscopy (NIRS) and Mid–Infrared Spectroscopy (MIRS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6.
    View at Publisher | View at Google Scholar
  32. A. Heidari, (2018), “Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Austin Pharmacol Pharm, 3 (1): 1011.
    View at Publisher | View at Google Scholar
  33. A. Heidari, (2017), “Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulation”, Madridge J Nov Drug Res, 1 (1): 18–24.
    View at Publisher | View at Google Scholar
  34. A. Heidari, (2018), “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Open Access J Trans Med Res, 2 (1): 00026–00032.
    View at Publisher | View at Google Scholar
  35. M. R. R. Gobato, R. Gobato, A. Heidari, (2018), “Planting of Jaboticaba Trees for Landscape Repair of Degraded Area”, Landscape Architecture and Regional Planning, Vol. 3, No. 1, Pages 1–9.
    View at Publisher | View at Google Scholar
  36. A. Heidari, (2018), “Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, SM J Clin. Med. Imaging, 4 (1): 1018.
    View at Publisher | View at Google Scholar
  37. A. Heidari, (2018), “Nuclear Inelastic Scattering Spectroscopy (NISS) and Nuclear Inelastic Absorption Spectroscopy (NIAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Pharm Sci, 2 (1): 1–14.
    View at Publisher | View at Google Scholar
  38. A. Heidari, (2018), “X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Oncol Res; 2 (1): 1–14.
    View at Publisher | View at Google Scholar
  39. A. Heidari, (2018), “Correlation Two–Dimensional Nuclear Magnetic Reso¬nance (NMR) (2D–NMR) (COSY) Imaging and Spectrosco¬py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Can Sci, 1–1–001.
    View at Publisher | View at Google Scholar
  40. A. Heidari, (2018), “Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, SM J Biometrics Biostat, 3 (1): 1024.
    View at Publisher | View at Google Scholar
  41. 41.A. Heidari, (2018), “A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’ Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy”, Open Acc J Oncol Med. 1 (1).
    View at Publisher | View at Google Scholar
  42. A. Heidari, (2018), “Heteronuclear Correlation Experiments Such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiation”, J Endocrinol Thyroid Res, 3 (1): 555603.
    View at Publisher | View at Google Scholar
  43. A. Heidari, (2018),“Nuclear Resonance Vibrational Spectroscopy (NRVS), Nuclear Inelastic Scattering Spectroscopy (NISS), Nuclear Inelastic Absorption Spectroscopy (NIAS) and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (1e): 1–5.
    View at Publisher | View at Google Scholar
  44. A. Heidari, (2018), “A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiation”, Glob J Endocrinol Metab. 1 (3). GJEM. 000514–000519.
    View at Publisher | View at Google Scholar
  45. A. Heidari, (2018), “Pros and Cons Controversy on Heteronuclear Correlation Experiments Such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Pharma J. 1 (1): 002–008.
    View at Publisher | View at Google Scholar
  46. A. Heidari, (2018), “A Modern Comparative and Comprehensive Experimental Biospectroscopic Study on Different Types of Infrared Spectroscopy of Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, J Analyt Molecul Tech. 3 (1): 8.
    View at Publisher | View at Google Scholar
  47. A. Heidari, (2018), “Investigation of Cancer Types Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, European Modern Studies Journal, Vol. 2, No. 1, 13–29.
    View at Publisher | View at Google Scholar
  48. A. Heidari, (2018), “Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Imaging J Clin Medical Sci. 5 (1): 001–007.
    View at Publisher | View at Google Scholar
  49. A. Heidari, (2018), “Small–Angle Neutron Scattering (SANS) and Wide–Angle X–Ray Diffraction (WAXD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (2e): 1–6.
    View at Publisher | View at Google Scholar
  50. A. Heidari, (2018), “Investigation of Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver, Lung Cancer, Melanoma, Non–Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer and Non–Melanoma Skin Cancer Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, Ther Res Skin Dis 1 (1).
    View at Publisher | View at Google Scholar
  51. A. Heidari, (2018), “Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy and Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, International Journal of Chemistry Papers, 2 (1): 1–12.
    View at Publisher | View at Google Scholar
  52. A. Heidari, (2018), “Mössbauer Spectroscopy, Mössbauer Emission Spectroscopy and 57Fe Mössbauer Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Cancer Biology 2.3: 17–20, 2018.
    View at Publisher | View at Google Scholar
  53. A. Heidari, (2018), “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Organic & Medicinal Chem IJ. 6 (1): 555676.
    View at Publisher | View at Google Scholar
  54. A. Heidari, (2018), “Correlation Spectroscopy, Exclusive Correlation Spectroscopy and Total Correlation Spectroscopy Comparative Study on Malignant and Benign Human AIDS–Related Cancers Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Bioanal Biomed. 2 (1): 001–007.
    View at Publisher | View at Google Scholar
  55. A. Heidari, (2018), “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Delivery”, Am J Nanotechnol Nanomed. 1 (1): 001–009.
    View at Publisher | View at Google Scholar
  56. A. Heidari, (2018), “Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Ann Biomet Biostat. 1 (1): 1001.
    View at Publisher | View at Google Scholar
  57. A. Heidari, (2018), “Grazing–Incidence Small–Angle Neutron Scattering (GISANS) and Grazing–Incidence X–Ray Diffraction (GIXD) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron Radiation”, Ann Cardiovasc Surg. 1 (2): 1006.
    View at Publisher | View at Google Scholar
  58. A. Heidari, (2018), “Adsorption Isotherms and Kinetics of Multi–Walled Carbon Nanotubes (MWCNTs), Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) for Eliminating Carcinoma, Sarcoma, Lymphoma, Leukemia, Germ Cell Tumor and Blastoma Cancer Cells and Tissues”, Clin Med Rev Case Rep 5: 201.
    View at Publisher | View at Google Scholar
  59. A. Heidari, (2018), “Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Pharmaceutical Sciences 2.5: 30–35.
    View at Publisher | View at Google Scholar
  60. A. Heidari, (2018), “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing–Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Oncol Res Rev, Volume 1 (1): 1–10.
    View at Publisher | View at Google Scholar
  61. A. Heidari, (2018),“Pump–Probe Spectroscopy and Transient Grating Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Adv Material Sci Engg, Volume 2, Issue 1, Pages 1–7, 2018.
    View at Publisher | View at Google Scholar
  62. A. Heidari, (2018), “Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS) and Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Insights Pharmacol Pharm Sci 1 (1): 1–8.
    View at Publisher | View at Google Scholar
  63. A. Heidari, (2018), “Acoustic Spectroscopy, Acoustic Resonance Spectroscopy and Auger Spectroscopy Comparative Study on Anti–Cancer Nano Drugs Delivery in Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Nanosci Technol 5 (1): 1–9.
    View at Publisher | View at Google Scholar
  64. 64.A. Heidari, (2018), “Niobium, Technetium, Ruthenium, Rhodium, Hafnium, Rhenium, Osmium and Iridium Ions Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Nanomed Nanotechnol, 3 (2): 000138.
    View at Publisher | View at Google Scholar
  65. A. Heidari, (2018), “Homonuclear Correlation Experiments Such as Homonuclear Single–Quantum Correlation Spectroscopy (HSQC), Homonuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Homonuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Austin J Proteomics Bioinform & Genomics. 5 (1): 1024.
    View at Publisher | View at Google Scholar
  66. A. Heidari, (2018), “Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy and Nuclear Resonance Vibrational Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Appl Biotechnol Bioeng. 5 (3): 142‒148.
    View at Publisher | View at Google Scholar
  67. A. Heidari, (2018),“Time–Dependent Vibrational Spectral Analysis of Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Cancer Oncol, 2 (2): 000124, 2018.
    View at Publisher | View at Google Scholar
  68. A. Heidari, (2018), “Palauamine and Olympiadane Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Arc Org Inorg Chem Sci 3 (1).
    View at Publisher | View at Google Scholar
  69. R. Gobato, A. Heidari, (2018), “Infrared Spectrum and Sites of Action of Sanguinarine by Molecular Mechanics and Ab Initio Methods”, International Journal of Atmospheric and Oceanic Sciences. Vol. 2, No. 1, pp. 1–9.
    View at Publisher | View at Google Scholar
  70. A. Heidari, (2018), “Angelic Acid, Diabolic Acids, Draculin and Miraculin Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Med & Analy Chem Int J, 2 (1): 000111.
    View at Publisher | View at Google Scholar
  71. A. Heidari, (2018), “Gamma Linolenic Methyl Ester, 5–Heptadeca–5,8,11–Trienyl 1,3,4–Oxadiazole–2–Thiol, Sulphoquinovosyl Diacyl Glycerol, Ruscogenin, Nocturnoside B, Protodioscine B, Parquisoside–B, Leiocarposide, Narangenin, 7–Methoxy Hespertin, Lupeol, Rosemariquinone, Rosmanol and Rosemadiol Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Int J Pharma Anal Acta, 2 (1): 007–014.
    View at Publisher | View at Google Scholar
  72. A. Heidari, (2018), “Fourier Transform Infrared (FTIR) Spectroscopy, Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy, Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy, Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy, Non–Linear Two–Dimensional Infrared Spectroscopy, Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy, Infrared Photodissociation Spectroscopy, Infrared Correlation Table Spectroscopy, Near–Infrared Spectroscopy (NIRS), Mid–Infrared Spectroscopy (MIRS), Nuclear Resonance Vibrational Spectroscopy, Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (2): 1–14.
    View at Publisher | View at Google Scholar
  73. 73.A. Heidari, (2018), “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations”, Chronicle of Medicine and Surgery 2.3: 144–156.
    View at Publisher | View at Google Scholar
  74. A. Heidari, (2018), “Tetrakis [3, 5–bis (Trifluoromethyl) Phenyl] Borate (BARF)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Medical Research and Clinical Case Reports 2.1: 113–126.
    View at Publisher | View at Google Scholar
  75. A. Heidari, (2018), “Sydnone, Münchnone, Montréalone, Mogone, Montelukast, Quebecol and Palau’amine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Sur Cas Stud Op Acc J. 1 (3).
    View at Publisher | View at Google Scholar
  76. A. Heidari, (2018), “Fornacite, Orotic Acid, Rhamnetin, Sodium Ethyl Xanthate (SEX) and Spermine (Spermidine or Polyamine) Nanomolecules Incorporation into the Nanopolymeric Matrix (NPM)”, International Journal of Biochemistry and Biomolecules, Vol. 4: Issue 1, Pages 1–19.
    View at Publisher | View at Google Scholar
  77. A. Heidari, R. Gobato, (2018), “Putrescine, Cadaverine, Spermine and Spermidine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Parana Journal of Science and Education (PJSE)–v.4, n.5, (1–14) July 1.
    View at Publisher | View at Google Scholar
  78. 78.A. Heidari, (2018), “Cadaverine (1,5–Pentanediamine or Pentamethylenediamine), Diethyl Azodicarboxylate (DEAD or DEADCAT) and Putrescine (Tetramethylenediamine) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Hiv and Sexual Health Open Access Open Journal. 1 (1): 4–11.
    View at Publisher | View at Google Scholar
  79. A. Heidari, (2018), “Improving the Performance of Nano–Endofullerenes in Polyaniline Nanostructure–Based Biosensors by Covering Californium Colloidal Nanoparticles with Multi–Walled Carbon Nanotubes”, Journal of Advances in Nanomaterials, Vol. 3, No. 1, Pages 1–28.
    View at Publisher | View at Google Scholar
  80. R. Gobato, A. Heidari, (2018), “Molecular Mechanics and Quantum Chemical Study on Sites of Action of Sanguinarine Using Vibrational Spectroscopy Based on Molecular Mechanics and Quantum Chemical Calculations”, Malaysian Journal of Chemistry, Vol. 20 (1), 1–23.
    View at Publisher | View at Google Scholar
  81. A. Heidari, (2018), “Vibrational Biospectroscopic Studies on Anti–Cancer Nanopharmaceuticals (Part I)”, Malaysian Journal of Chemistry, Vol. 20 (1), 33–73.
    View at Publisher | View at Google Scholar
  82. A. Heidari, (2018),“Vibrational Biospectroscopic Studies on Anti–Cancer Nanopharmaceuticals (Part II)”, Malaysian Journal of Chemistry, Vol. 20 (1), 74–117.
    View at Publisher | View at Google Scholar
  83. A. Heidari, (2018), “Uranocene (U(C8H8)2) and Bis(Cyclooctatetraene)Iron (Fe(C8H8)2 or Fe(COT)2)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Chemistry Reports, Vol. 1, Iss. 2, Pages 1–16.
    View at Publisher | View at Google Scholar
  84. A. Heidari, (2018), “Biomedical Systematic and Emerging Technological Study on Human Malignant and Benign Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (3): 1–7.
    View at Publisher | View at Google Scholar
  85. A. Heidari, (2018), “Deep–Level Transient Spectroscopy and X–Ray Photoelectron Spectroscopy (XPS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Res Dev Material Sci. 7(2). RDMS.000659.
    View at Publisher | View at Google Scholar
  86. A. Heidari, (2018), “C70–Carboxyfullerenes Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (3): 1–7.
    View at Publisher | View at Google Scholar
  87. A. Heidari, (2018), “The Effect of Temperature on Cadmium Oxide (CdO) Nanoparticles Produced by Synchrotron Radiation in the Human Cancer Cells, Tissues and Tumors”, International Journal of Advanced Chemistry, 6 (2) 140–156.
    View at Publisher | View at Google Scholar
  88. A. Heidari, (2018), “A Clinical and Molecular Pathology Investigation of Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations Using Cyclotron versus Synchrotron, Synchrocyclotron and the Large Hadron Collider (LHC) for Delivery of Proton and Helium Ion (Charged Particle) Beams for Oncology Radiotherapy”, European Journal of Advances in Engineering and Technology, 5 (7): 414–426.
    View at Publisher | View at Google Scholar
  89. A. Heidari, (2018), “Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, J Oncol Res; 1 (1): 1–20.
    View at Publisher | View at Google Scholar
  90. A. Heidari, (2018), “Use of Molecular Enzymes in the Treatment of Chronic Disorders”, Canc Oncol Open Access J. 1 (1): 12–15.
    View at Publisher | View at Google Scholar
  91. A. Heidari, (2018), “Vibrational Biospectroscopic Study and Chemical Structure Analysis of Unsaturated Polyamides Nanoparticles as Anti–Cancer Polymeric Nanomedicines Using Synchrotron Radiation”, International Journal of Advanced Chemistry, 6 (2) 167–189.
    View at Publisher | View at Google Scholar
  92. A. Heidari, (2018), “Adamantane, Irene, Naftazone and Pyridine–Enhanced Precatalyst Preparation Stabilization and Initiation (PEPPSI) Nano Molecules”, Madridge J Nov Drug Res. 2 (1): 61–67.
    View at Publisher | View at Google Scholar
  93. A. Heidari, (2018), “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Madridge J Nov Drug Res, 2 (1): 68–74.
    View at Publisher | View at Google Scholar
  94. A. Heidari, R. Gobato, (2018), “A Novel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNA of Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic Acid Diethyl Amide or LSD), Δ⁹–Tetrahydrocannabinol (THC) [(–)–trans–Δ⁹–Tetrahydrocannabinol], Theobromine (Xantheose), Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV) [Azidothymidine (AZT)] as Anti–Cancer Nano Drugs by Coassembly of Dual Anti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistance”, Parana Journal of Science and Education (PJSE), v. 4, n. 6, pp. 1–17.
    View at Publisher | View at Google Scholar
  95. A. Heidari, R. Gobato, (2018), “Ultraviolet Photoelectron Spectroscopy (UPS) and Ultraviolet–Visible (UV–Vis) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Parana Journal of Science and Education (PJSE), v. 4, n. 6, pp. 18–33.
    View at Publisher | View at Google Scholar
  96. R. Gobato, A. Heidari, A. Mitra, (2018), “The Creation of C13H20BeLi2SeSi. The Proposal of a Bio–Inorganic Molecule, Using Ab Initio Methods for the Genesis of a Nano Membrane”, Arc Org Inorg Chem Sci 3 (4). AOICS.MS.ID.000167.
    View at Publisher | View at Google Scholar
  97. R. Gobato, A. Heidari, (2018), “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, J Nanomed Res.7 (4): 241‒252.
    View at Publisher | View at Google Scholar
  98. A. Heidari, (2018), “Bastadins and Bastaranes–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Glob Imaging Insights, Volume 3 (4): 1–7.
    View at Publisher | View at Google Scholar
  99. A. Heidari, (2018), “Fucitol, Pterodactyladiene, DEAD or DEADCAT (DiEthyl AzoDiCArboxylaTe), Skatole, the NanoPutians, Thebacon, Pikachurin, Tie Fighter, Spermidine and Mirasorvone Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4): 1–8.
    View at Publisher | View at Google Scholar
  100. E. Dadvar, A. Heidari, (2018), “A Review on Separation Techniques of Graphene Oxide (GO)/Base on Hybrid Polymer Membranes for Eradication of Dyes and Oil Compounds: Recent Progress in Graphene Oxide (GO)/Base on Polymer Membranes–Related Nanotechnologies”, Clin Med Rev Case Rep 5: 228.
    View at Publisher | View at Google Scholar
  101. A. Heidari, R. Gobato, (2018), “First–Time Simulation of Deoxyuridine Monophosphate (dUMP) (Deoxyuridylic Acid or Deoxyuridylate) and Vomitoxin (Deoxynivalenol (DON)) ((3α,7α)–3,7,15–Trihydroxy–12,13–Epoxytrichothec–9–En–8–One)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Parana Journal of Science and Education (PJSE), Vol. 4, No. 6, pp. 46–67.
    View at Publisher | View at Google Scholar
  102. A. Heidari, (2018), “Buckminsterfullerene (Fullerene), Bullvalene, Dickite and Josiphos Ligands Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Hematology and Thromboembolic Diseases Prevention, Diagnosis and Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4): 1–7.
    View at Publisher | View at Google Scholar
  103. A. Heidari, (2018), “Fluctuation X–Ray Scattering (FXS) and Wide–Angle X–Ray Scattering (WAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (4): 1–7.
    View at Publisher | View at Google Scholar
  104. A. Heidari, (2018),“A Novel Approach to Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–9.
    View at Publisher | View at Google Scholar
  105. A. Heidari, (2018), “Terphenyl–Based Reversible Receptor with Rhodamine, Rhodamine–Based Molecular Probe, Rhodamine–Based Using the Spirolactam Ring Opening, Rhodamine B with Ferrocene Substituent, Calix[4]Arene–Based Receptor, Thioether + Aniline–Derived Ligand Framework Linked to a Fluorescein Platform, Mercuryfluor–1 (Flourescent Probe), N,N’–Dibenzyl–1,4,10,13–Tetraraoxa–7,16–Diazacyclooctadecane and Terphenyl–Based Reversible Receptor with Pyrene and Quinoline as the Fluorophores–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Glob Imaging Insights, Volume 3 (5): 1–9.
    View at Publisher | View at Google Scholar
  106. A. Heidari, (2018), “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing– Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–10.
    View at Publisher | View at Google Scholar
  107. A. Heidari, (2018), “Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) and Nuclear Resonance Vibrational Spectroscopy (NRVS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–7.
    View at Publisher | View at Google Scholar
  108. A. Heidari, (2018), “Small–Angle X–Ray Scattering (SAXS) and Ultra–Small Angle X–Ray Scattering (USAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–7.
    View at Publisher | View at Google Scholar
  109. A. Heidari, (2018), “Curious Chloride (CmCl3) and Titanic Chloride (TiCl4)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules for Cancer Treatment and Cellular Therapeutics”, J. Cancer Research and Therapeutic Interventions, Volume 1, Issue 1, Pages 01–10.
    View at Publisher | View at Google Scholar
  110. R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, (2018), “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd)”, Arc Org Inorg Chem Sci 3 (5), Pages 402–409.
    View at Publisher | View at Google Scholar
  111. A. Heidari, (2018), “C60 and C70–Encapsulating Carbon Nanotubes Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Integr Mol Med, Volume 5 (3): 1–8.
    View at Publisher | View at Google Scholar
  112. A. Heidari, (2018), “Two–Dimensional (2D) 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6): 1–8.
    View at Publisher | View at Google Scholar
  113. A. Heidari, (2018), “FT–Raman Spectroscopy, Coherent Anti–Stokes Raman Spectroscopy (CARS) and Raman Optical Activity Spectroscopy (ROAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6): 1–8.
    View at Publisher | View at Google Scholar
  114. A. Heidari, (2018), “A Modern and Comprehensive Investigation of Inelastic Electron Tunneling Spectroscopy (IETS) and Scanning Tunneling Spectroscopy on Malignant and Benign Human Cancer Cells, Tissues and Tumors through Optimizing Synchrotron Microbeam Radiotherapy for Human Cancer Treatments and Diagnostics: An Experimental Biospectroscopic Comparative Study”, Glob Imaging Insights, Volume 3 (6): 1–8.
    View at Publisher | View at Google Scholar
a